Robert Bandanza
September 29th, 2006, 12:49 PM
Acid reflux may raise risk of cancer
By Amy Norton in New York
September 29, 2006 11:37pm
PEOPLE with chronic stomach acid reflux may have an increased risk of developing cancer of the larynx, a study suggests.
Gastroesophageal reflux disease (GERD) has been considered a possible risk factor for laryngeal cancer, in large part because GERD is common among people with the cancer.
NEWS.com.au (http://www.news.com.au/story/0,23599,20501390-1702,00.html)
Scott Clarke
September 29th, 2006, 04:09 PM
Oh great, yet another thing I gotta worry about. :(
Robert Bandanza
September 29th, 2006, 04:30 PM
Oh great, yet another thing I gotta worry about. :(
Yeah, I got acid reflux as well. I take Prevacid for it, but if I ever forget to take it for a short while my throat burns severely and is really painful.
Action Alert
September 29th, 2006, 05:06 PM
Yeah, I got acid reflux as well. I take Prevacid for it, but if I ever forget to take it for a short while my throat burns severely and is really painful.
Individual results may vary. Prevacid Capsules, Prevacid for Oral Suspension and Prevacid SoluTab (lansoprazole) Orally Disintegrating Tablets may not be right for everyone. Prevacid has a low occurrence of side effects in adults and children including diarrhea, abdominal pain, nausea, dizziness, constipation and headache. Symptom relief does not rule out other serious stomach conditions.
Please see the complete Prescribing Information for more information and talk to your child's doctor.
If you suffer from persistent heartburn two or more days a week, despite treatment and diet changes, it could be acid reflux disease. Prescription Prevacid Capsules, Prevacid for Oral Suspension, and Prevacid SoluTab (lansoprazole) Orally Disintegrating Tablets are used for the treatment of acid reflux disease including erosive esophagitis, and may not be right for everyone. Your results may vary. Prevacid is generally well tolerated and has a low occurrence of side effects such as diarrhea, abdominal pain and nausea. Symptom relief does not rule out other serious stomach conditions. Talk to your doctor or healthcare professional to see if Prevacid is right for you. Prevacid products should not be crushed or chewed.
Please see the complete Prescribing Information for more information and talk to your doctor.
Important Safety Information for Prevacid NapraPAC (lansoprazole delayed-release capsules and naproxen tablets kit)
With Prescription Prevacid NapraPAC, people with a history of gastric ulcer can continue treatment for osteoarthritis and rheumatoid arthritis, and reduce the risk of stomach ulcer from coming back. Your results may vary. Controlled studies were conducted up to 12 weeks.
You should not take Naprosyn if you've had aspirin-sensitive asthma or allergic reactions to aspirin or other arthritis medicines. In rare cases, continued use of arthritis medicines may lead to serious stomach problems, such as bleeding, without warning signs. You should not take Naprosyn if you are taking other medications containing naproxen, such as Aleve® (naproxen sodium) or Anaprox® (naproxen sodium).
Tell your doctor if you have liver, kidney or fluid retention problems. Naprosyn should not be taken in late pregnancy. If you experience drowsiness or dizziness while taking Naprosyn, you should exercise caution when performing activities that require alertness.
The most frequently reported side effects of Naprosyn, with incidence between three and nine percent were constipation, heartburn, abdominal pain, nausea, headache, dizziness, drowsiness, itching, skin eruptions, ecchymosis (bruising), tinnitus (ringing in the ear), edema (excess fluid in tissues) and dyspnea (shortness of breath).
Please see the complete Prescribing Information for PREVACID NapraPAC for more information and talk to your doctor.
Naprosyn and NapraPAC are trademarks of Syntex Pharmaceuticals International Ltd. Aleve and Anaprox are not trademarks of TAP Pharmaceutical Products Inc.
vBulletin® v3.8.6, Copyright ©2000-2014, Jelsoft Enterprises Ltd.